Tarsus Pharmaceuticals In...

NASDAQ: TARS · Real-Time Price · USD
54.95
0.81 (1.50%)
At close: Aug 15, 2025, 12:49 PM

Tarsus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-115.55M -135.89M -62.09M -13.83M
Depreciation & Amortization
1.23M 877K 325K 312K
Stock-Based Compensation
27.82M 19.83M 13.46M 8.46M
Other Working Capital
-4.31M 4.3M -1.77M -2.51M
Other Non-Cash Items
-360K -2.61M 227K 5.79M
Deferred Income Tax
n/a n/a n/a 1.65M
Change in Working Capital
3.84M 306K -951K 1.37M
Operating Cash Flow
-83.03M -117.49M -49.03M 3.75M
Capital Expenditures
-1.57M -1.5M -506K -586K
Cash Acquisitions
n/a n/a 144.12M n/a
Purchase of Investments
-265.63M -28.66M -149.44M n/a
Sales Maturities Of Investments
73M 174.77M 5.32M n/a
Other Investing Acitivies
-5M -4M -144.12M n/a
Investing Cash Flow
-199.19M 140.6M -144.63M -586K
Debt Repayment
75M 10M 20M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-18.63M 1.58M -365K 21K
Financial Cash Flow
154.66M 130.18M 93.99M 21K
Net Cash Flow
-127.57M 153.29M -99.67M 3.18M
Free Cash Flow
-84.59M -123M -49.54M 3.16M